Igene Biotechnology, Inc.
IGNE · OTC
12/31/2009 | 12/31/2008 | 12/31/2007 | 12/31/2006 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$141 | -$3,991 | -$1,899 | -$1,156 |
| Dep. & Amort. | $151 | $108 | $12 | $16 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $2,094 | $7,349 | $1,660 | $942 |
| Other Non-Cash | -$2,201 | -$2,760 | $1,537 | $198 |
| Operating Cash Flow | -$97 | $706 | $1,310 | $0 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$172 | -$226 | -$275 | $0 |
| Net Acquisitions | $0 | $0 | -$108 | -$109 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $20 | $0 |
| Investing Cash Flow | -$172 | -$226 | -$363 | -$109 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $57 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $11 |
| Financing Cash Flow | $0 | $0 | $57 | $11 |
| Forex Effect | $76 | -$18 | $0 | $0 |
| Net Chg. in Cash | -$193 | $462 | $1,005 | -$98 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,488 | $1,026 | $22 | $120 |
| End Cash | $1,295 | $1,488 | $1,026 | $22 |
| Free Cash Flow | -$269 | $479 | $1,035 | $0 |